Navigation Links
Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases
Date:11/6/2007

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- A new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) finds that America's pharmaceutical research companies are now testing 338 new medicines to help treat infectious diseases, including 11 medicines and four vaccines to treat staphococcal infections. This is particularly important in light of increased public concern about the spread of methicillin-resistant staphylococcus aureus (MRSA) infections -- a strain of staph that has become resistant to current treatments.

"Staph poses a serious pubic health threat that we are committed to fighting," PhRMA President and CEO Billy Tauzin said. "America's pharmaceutical research companies are working hard to develop new medicines that will treat staph and even prevent patients from infection in the first place."

Although scientists say infectious diseases will never be completely eliminated, new research and commitment of resources by both the government and pharmaceutical research companies can help meet the continuing - and ever-changing - threat from infectious diseases. These 338 medicines in development will help combat humankind's oldest and most tenacious enemy: infectious diseases.

Among the new medicines now being tested are 146 vaccines to prevent diseases such as smallpox and staph; 83 antibiotics/antibacterials to treat infections such as pneumonia and tuberculosis; 75 antivirals to treat such viruses as hepatitis and influenza; and, 25 antifungals.

According to the report, the medicines in development include:

--A first-in-class medicine designed specifically to inhibit drug-resistant strains of Staphylococcus aureus.

--A medicine for the treatment of hepatitis C that is part of a new class of drugs to regulate innate immunity.

--A medicine that stops the life cycle of the bacterium that causes tuberculosis.

Other medicines are in development for treatment of fu
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... England , July 22, 2014 ... development and device company focused on solid dose ... its novel solid formulation of octreotide acetate achieved ... it with the currently marketed liquid product (Sandostatin®). ... transfer the formulation production process to a contract ...
(Date:7/21/2014)... /PRNewswire-iReach/ -- Nitrosolution.com, a website that features safe and ... first anniversary in August. The online retailer specializes in ... body,s ability to produce nitric oxide. Called Nitroxyl, it ... a variety of phytonutrients and other natural ingredients that ... nitric oxide production in the arteries and ...
(Date:7/21/2014)... , July 21, 2014 Thoratec Corporation (NASDAQ: ... mechanical circulatory support therapies to save, support and restore ... operating results for the second quarter of fiscal year ... will hold a conference call to discuss its financial ... at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern ...
Breaking Medicine Technology:Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide 2Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2Thoratec Schedules Second Quarter Conference Call, Webcast 2
... 12 Lexicon,Pharmaceuticals, Inc. (Nasdaq: LXRX ) ... drug (IND) application to the U.S. Food and ... for rheumatoid,arthritis and other autoimmune conditions. The initial ... a double-blind, randomized,placebo-controlled, ascending single-dose study in healthy ...
... Medical Lasers Limited,(ASX: ELX), a global leader in ... systems, announced today initial clinical results of,an ongoing ... demonstrate the therapy,s potential to improve and,stabilize visual ... with,diabetic maculopathy and macular edema without causing any ...
Cached Medicine Technology:Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 2Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 2Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 4
(Date:7/22/2014)... The market for botulinum neurotoxin (BoNT) products ... to novel medical indications created and due to more ... where physical appearance is extremely valued. Although the BoNT ... new companies and technologies are setting ground for biosuperiors ... the price of 1st-gen products under pressure, only innovation ...
(Date:7/22/2014)... NJ (PRWEB) July 22, 2014 CarePoint Health ... recently elected as the President of the medical staff at ... Levine will serve as President, as voted on by the ... of the medical staff in relation to the administration at ... needs of physicians and to work to make the Medical ...
(Date:7/22/2014)... The Middle East Drilling fluid and Completion fluid Market ... market in Middle East with analysis and forecast of revenue. ... is estimated to grow from around $560 million in 2013 ... for the given period. , Browse through the TOC of ... to get an idea of the in-depth analysis provided. This ...
(Date:7/22/2014)... Over the years, medical science ... of human anatomy. In the pursuit, pathological sciences, ... the possibility of deploying certain tests that are ... in order to detect the presence of concerning ... Diagnostics (IVD) have earned the title of ‘silent ...
(Date:7/22/2014)... How can women meet the demands of a professorship ... a mother has a profound effect on the career ... physical sciences. Yet many women successfully manage to do ... fifteen inspirational personal accounts describe the challenges and rewards ... , The authors of the contributions are all women ...
Breaking Medicine News(10 mins):Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 4
... Calif., June 23 Consumer,Watchdog warned today that a ... it,more difficult for patients to recover unpaid medical bills ... illegal and,unwarranted. The legislation and recent settlements with regulators ... from legal,liability under the guise of reform., AB ...
... patients who need little, if any, immune suppression , , ... called HLA-G dimer plays a powerful role in preventing ... Medical College of Georgia researchers say. , They ... mice and are currently studying whether this molecule is ...
... than 15 years ago scientists discovered a way to ... Prize-winning finding holds tantalizing promise for medical science, but ... technique, known as RNA interference, in living cells., Now ... Emory University in Atlanta have succeeded in using nanotechnology ...
... 23 Quest Diagnostics,Incorporated (NYSE: DGX ), ... services, announced that it is scheduled to speak,at ... 2008. The Quest,Diagnostics presentation is scheduled to begin ... be webcast live during the conference and will ...
... Ky., June 23 The following open,letter to Senator ... "Quitting isn,t that easy, ChicagoTribune.com, June 22, ... great interest your recent comments about your struggle,to quit ... research,program focused on tobacco use and its consequences, I ...
... Crash Diets Often Crash-and-Burn, WASHINGTON, June 23 ... weighed in today on a,weight-loss story in the headlines, ... little more than a crash diet, not the kind ... Chris Coleson, a 42-year old Quinton, Virginia man ...
Cached Medicine News:Health News:CA Legislature's 'Reform' of Health Insurance Cancellations Resembles Insurance Industry's Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill 2Health News:CA Legislature's 'Reform' of Health Insurance Cancellations Resembles Insurance Industry's Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill 3Health News:CA Legislature's 'Reform' of Health Insurance Cancellations Resembles Insurance Industry's Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill 4Health News:CA Legislature's 'Reform' of Health Insurance Cancellations Resembles Insurance Industry's Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill 5Health News:Immune Molecule Key to Preventing Organ Rejection 2Health News:Gene silencer and quantum dots reduce protein production to a whisper 2Health News:Gene silencer and quantum dots reduce protein production to a whisper 3Health News:'Quitting Isn't That Easy' 2Health News:'Quitting Isn't That Easy' 3Health News:Experts Fact-Check 'McDonald's Diet' Story 2
... To aid clinicians in performing Ankle/Brachial ... a new, complete packet of information. It ... presentation that can be viewed on any ... the step-by-step procedure of performing an ABI ...
... Auto Refractor/Keratometer. Advanced engineering, ... retro illumination mode make it the ... use. 5.5 inch High Quality ... focusing. Rapid, instantaneous readings are taken ...
... for Urinary Tract Infection (UTI) ... A multi-center study was conducted ... UTIs. There were 1,887 urine ... and nitrite results of Multistix ...
... PocketChem UA is the first ... take up valuable lab bench space. ... the variability in results between operators ... on every run, corrects for ambient ...
Medicine Products: